Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

300
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
300

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The experimental study on the effect of the NRF2 activator dimethyl itaconate on hypoxia-induced scleral fibroblasts].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2025
Same author

Phenome-wide association study identifies dsDNA as a driver of major organ involvement in systemic lupus erythematosus.

Lupus·2018
Same author

Effects of health education intervention on negative emotion and quality of life of patients with laryngeal cancer after postoperative radiotherapy.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Same author

Representing Knowledge Consistently Across Health Systems.

Yearbook of medical informatics·2017
Same author

The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.

The pharmacogenomics journal·2016
Same author

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

Clinical pharmacology and therapeutics·2016
Same journal

Optimizing Clinical Decision Support for Antibiotic Prescribing in Pediatric Acute Respiratory Tract Infections: A Usability Study.

Applied clinical informatics·2026
Same journal

Disparities in Activation and Use of Patient Portals Among Spanish-Speaking Patients.

Applied clinical informatics·2026
Same journal

Real-World Utilization of a Hospital-Integrated Internet Hospital in Henan Province, China: A 1-Year Observational Study.

Applied clinical informatics·2026
Same journal

From Pandemic Response to Kill the Clipboard: Patient-Controlled Sharing of Health Data Using International Patient Summary (IPS) and QR codes.

Applied clinical informatics·2026
Same journal

Usage of and Satisfaction with Artificial Intelligence-Generated Draft Replies to Patient Portal Messages.

Applied clinical informatics·2026
Same journal

Automating Ambulatory Central Line Data Capture and Calculations.

Applied clinical informatics·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.9K

Lessons learned from developing a drug evidence base to support pharmacovigilance.

J C Smith1, J C Denny, Q Chen

  • 1Department of Biomedical Informatics, Vanderbilt University School of Medicine , Nashville, Tennessee, USA.

Applied Clinical Informatics
|January 24, 2014
PubMed
Summary
This summary is machine-generated.

Extracting medication information from public sources presents challenges. Current systems struggle with uniform representation and complexity, leading to inaccuracies in drug indications and adverse effects (ADEs).

Keywords:
Drug therapyadverse effectsdrug product labelingknowledge basesunified medical language system

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Related Experiment Videos

Last Updated: May 3, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.9K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Area of Science:

  • Pharmacovigilance and Drug Informatics
  • Medical Informatics
  • Computational Linguistics in Medicine

Background:

  • Publicly available electronic sources are crucial for medication-related information.
  • Challenges exist in extracting and representing drug indications and adverse effects (ADEs).

Purpose of the Study:

  • To identify challenges in extracting and representing medication information from public electronic sources.
  • To evaluate the utility of existing drug information resources.

Main Methods:

  • Created and evaluated the Drug Evidence Base (DEB).
  • Extracted content from National Drug File Reference Terminology, MEDLINE co-occurrence data, and DailyMed.
  • Conducted statistical evaluations and human expert reviews comparing DEB with SIDER and MEDI resources.

Main Results:

  • DEB, SIDER, and MEDI showed agreement but had limitations.
  • Resources used disparate UMLS concepts for single indications/ADEs, causing false matches.
  • Complex logical and temporal relationships of indications/ADEs are difficult to represent.

Conclusions:

  • Future drug information systems need uniform and precise clinical concept representation.
  • Systems must better capture the complexity of indications and ADEs for enhanced utility.